Correlation Between Amylyx Pharmaceuticals and Compass Therapeutics
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Compass Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Compass Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Compass Therapeutics, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Compass Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Compass Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Compass Therapeutics.
Diversification Opportunities for Amylyx Pharmaceuticals and Compass Therapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Amylyx and Compass is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Compass Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Therapeutics and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Compass Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Therapeutics has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Compass Therapeutics go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and Compass Therapeutics
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 1.24 times more return on investment than Compass Therapeutics. However, Amylyx Pharmaceuticals is 1.24 times more volatile than Compass Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Compass Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 533.00 in Amylyx Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 33.00 from holding Amylyx Pharmaceuticals or generate 6.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amylyx Pharmaceuticals vs. Compass Therapeutics
Performance |
| Timeline |
| Amylyx Pharmaceuticals |
| Compass Therapeutics |
Amylyx Pharmaceuticals and Compass Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amylyx Pharmaceuticals and Compass Therapeutics
The main advantage of trading using opposite Amylyx Pharmaceuticals and Compass Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Compass Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Therapeutics will offset losses from the drop in Compass Therapeutics' long position.| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
| Compass Therapeutics vs. Eliem Therapeutics | Compass Therapeutics vs. HCW Biologics | Compass Therapeutics vs. Scpharmaceuticals | Compass Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |